CENPE expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.651800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.306800E-01
Normal-vs-Stage2
7.878200E-01
Normal-vs-Stage3
6.999000E-01
Normal-vs-Stage4
4.598800E-01
Stage1-vs-Stage2
2.985600E-01
Stage1-vs-Stage3
9.796800E-01
Stage1-vs-Stage4
1.872220E-01
Stage2-vs-Stage3
4.099800E-01
Stage2-vs-Stage4
4.687800E-01
Stage3-vs-Stage4
2.912000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.306600E-01
Normal-vs-AfricanAmerican
5.842600E-01
Normal-vs-Asian
9.270200E-01
Caucasian-vs-AfricanAmerican
3.814200E-01
Caucasian-vs-Asian
7.954200E-01
AfricanAmerican-vs-Asian
4.184800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.793200E-01
Normal-vs-Female
7.049800E-01
Male-vs-Female
9.106300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.869200E-01
Normal-vs-Age(41-60Yrs)
6.574200E-01
Normal-vs-Age(61-80Yrs)
9.988400E-01
Normal-vs-Age(81-100Yrs)
8.712000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.498200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.885600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.611600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.351700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.330200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.317000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.044600E-01
Normal-vs-Daily Drinker
9.967200E-01
Normal-vs-Weekly Drinker
7.756800E-01
Normal-vs-Occasional Drinker
6.271400E-01
Normal-vs-Social Drinker
9.550600E-01
Non Drinker-vs-Daily Drinker
8.003000E-01
Non Drinker-vs-Weekly Drinker
7.527800E-01
Non Drinker-vs-Occasional Drinker
5.179400E-01
Non Drinker-vs-Social Drinker
8.854800E-01
Daily Drinker-vs-Weekly Drinker
6.248000E-01
Daily Drinker-vs-Occasional Drinker
4.149400E-01
Daily Drinker-vs-Social Drinker
9.247600E-01
Weekly Drinker-vs-Occasional Drinker
8.005400E-01
Weekly Drinker-vs-Social Drinker
6.644000E-01
Occasional Drinker-vs-Social Drinker
4.381600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.502800E-01
Normal-vs-Grade 2
8.026800E-01
Normal-vs-Grade 3
8.084600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.502400E-03
Grade 1-vs-Grade 3
1.238060E-02
Grade 1-vs-Grade 4
6.502800E-01
Grade 2-vs-Grade 3
9.213800E-01
Grade 2-vs-Grade 4
8.026800E-01
Grade 3-vs-Grade 4
8.084600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.138200E-01
Normal-vs-NonDiabetic
8.148800E-01
Diabetic-vs-NonDiabetic
1.562420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.078600E-01
Normal-vs-NoPancreatitis
8.885000E-01
Pancreatitis-vs-NoPancreatitis
9.070200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.123800E-01
Normal-vs-N1
8.147600E-01
N0-vs-N1
6.524400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.796600E-01
Normal-vs-TP53-NonMutant
9.270800E-01
TP53-Mutant-vs-TP53-NonMutant
2.026700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
